Mel Bridges

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

Gtech International Resources Ltd. focuses on identifying and acquiring new business opportunities across Australia and Canada. Previously, it was in the process of exploring its mineral properties. The company was founded on May 28, 1968 and is headquartered in Fitzroy, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Gtech International Resources Ltd. focuses on identifying and acquiring new business opportunities across Australia and Canada. Previously, it was in the process of exploring its mineral properties. The company was founded on May 28, 1968 and is headquartered in Fitzroy, Australia.

AquaCarotene Ltd. is an Australian producer of organically certified dry marine algae that is rich in natural beta-carotene, a naturally occurring substance commonly found in red, orange, and green fruit and vegetables and other antioxidants. Aquacarotene's dry marine algae is made up of whole cells of the micro algae Dunaliella salina and the company has established biomass growth ponds, trial ponds, seawater holding ponds and plant and equipment in Karratha, which is located in North-Western Australia to grow Dunaliella salina. AquaCarotene also occupies two high ground mining leases of approximately 158 ha, which, are expected to generate intermittent revenue from the sale of general fill material currently being recovered. AquaCarotene is currently exploring other uses for its 380 ha of aquaculture lease, including biddies from micro algae and aquaculture. The company is headquartered in West Perth, Australia.

AquaCarotene Ltd. is an Australian producer of organically certified dry marine algae that is rich in natural beta-carotene, a naturally occurring substance commonly found in red, orange, and green fruit and vegetables and other antioxidants. Aquacarotene's dry marine algae is made up of whole cells of the micro algae Dunaliella salina and the company has established biomass growth ponds, trial ponds, seawater holding ponds and plant and equipment in Karratha, which is located in North-Western Australia to grow Dunaliella salina. AquaCarotene also occupies two high ground mining leases of approximately 158 ha, which, are expected to generate intermittent revenue from the sale of general fill material currently being recovered. AquaCarotene is currently exploring other uses for its 380 ha of aquaculture lease, including biddies from micro algae and aquaculture. The company is headquartered in West Perth, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Gtech International Resources Ltd. focuses on identifying and acquiring new business opportunities across Australia and Canada. Previously, it was in the process of exploring its mineral properties. The company was founded on May 28, 1968 and is headquartered in Fitzroy, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.

Arana Therapeutics Ltd. engages in researching and developing, investing, licensing, technology, producing, formulating and marketing peptides and related products for the human and animal pharmaceutical industries. It develops and provides human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals. The company was founded in 1985 and is headquartered in Macquarie Park, Australia.

AquaCarotene Ltd. is an Australian producer of organically certified dry marine algae that is rich in natural beta-carotene, a naturally occurring substance commonly found in red, orange, and green fruit and vegetables and other antioxidants. Aquacarotene's dry marine algae is made up of whole cells of the micro algae Dunaliella salina and the company has established biomass growth ponds, trial ponds, seawater holding ponds and plant and equipment in Karratha, which is located in North-Western Australia to grow Dunaliella salina. AquaCarotene also occupies two high ground mining leases of approximately 158 ha, which, are expected to generate intermittent revenue from the sale of general fill material currently being recovered. AquaCarotene is currently exploring other uses for its 380 ha of aquaculture lease, including biddies from micro algae and aquaculture. The company is headquartered in West Perth, Australia.

AquaCarotene Ltd. is an Australian producer of organically certified dry marine algae that is rich in natural beta-carotene, a naturally occurring substance commonly found in red, orange, and green fruit and vegetables and other antioxidants. Aquacarotene's dry marine algae is made up of whole cells of the micro algae Dunaliella salina and the company has established biomass growth ponds, trial ponds, seawater holding ponds and plant and equipment in Karratha, which is located in North-Western Australia to grow Dunaliella salina. AquaCarotene also occupies two high ground mining leases of approximately 158 ha, which, are expected to generate intermittent revenue from the sale of general fill material currently being recovered. AquaCarotene is currently exploring other uses for its 380 ha of aquaculture lease, including biddies from micro algae and aquaculture. The company is headquartered in West Perth, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

Gtech International Resources Ltd. focuses on identifying and acquiring new business opportunities across Australia and Canada. Previously, it was in the process of exploring its mineral properties. The company was founded on May 28, 1968 and is headquartered in Fitzroy, Australia.

Incitive Ltd. engages in research and technology. The Group's principal activities are in the research and development of anti-inflammatory and immunosuppressant drugs. The company was founded on August 10, 2005 and is headquartered in Brisbane, Australia.

AquaCarotene Ltd. is an Australian producer of organically certified dry marine algae that is rich in natural beta-carotene, a naturally occurring substance commonly found in red, orange, and green fruit and vegetables and other antioxidants. Aquacarotene's dry marine algae is made up of whole cells of the micro algae Dunaliella salina and the company has established biomass growth ponds, trial ponds, seawater holding ponds and plant and equipment in Karratha, which is located in North-Western Australia to grow Dunaliella salina. AquaCarotene also occupies two high ground mining leases of approximately 158 ha, which, are expected to generate intermittent revenue from the sale of general fill material currently being recovered. AquaCarotene is currently exploring other uses for its 380 ha of aquaculture lease, including biddies from micro algae and aquaculture. The company is headquartered in West Perth, Australia.